Pharmaceutical companies are relying on real-world data (RWD) to drive more meaningful analytics and turn historical and real-time data into profitable products.
This growth is especially driven by the adoption of real-world evidence (RWE) like patient health status, treatment data, and health reports collected routinely to facilitate more focused and connected pharmaceutical research. Implementing AI-based analytical tools doubles down on this trend and enables pharma companies to identify hidden patterns for rare-disease research and drug development. In the wake of this development, the global pharmaceutical analytics market is predicted to increase at a CAGR of 20 percent by 2027 to reach $9,308 million.
To put the spotlight on such developments in the industry, Pharma Tech Outlook illustrates how pharma enterprises are leveraging the latest technologies to effectively gain insights and optimize production. This edition also features thought leadership articles from subject matter experts on the ongoing trends, best practices, and recent innovations in the pharma analytics space. Some of the exclusive insights are authored by Saadia B. Chaudhry, Director, Clinical Trial Supply Management at Advanced Clinical, Philippe MARC, Executive Director, Global Head of Integrated Data Science at Novartis and Nan Shao, PhD, Corporate Vice President, Global Head of Analytics Strategy at Parexel. They shed light on topics such as proactive planning for clinical supply logistics, rapid data quality control solutions for cellular therapies, and increased data input for effective QA and compliance.
In this edition of Pharma Tech Outlook, we also bring to you the story of some of the top pharma analytics solution providers fostering unparalleled data optimizations for enterprises and helping grab accurate data insights for production. In the list, BioPharm Communications, stands out for its comprehensive analytics toolkit that provides strategic multi-channel and customizable analytical marketing strategies. We also bring you the story of BioSeeker Group for its flagship cancer drug development analytics solution. Verix, with its robust AI/ML platform,follows suit to provide dedicated analytical insights for pharma companies to make more efficient decision-making.
Through the following pages, we aim to shine a light on the innovative trends and latest developments in the pharma analytics segment. We would like to know your thoughts.
